126 results
Page 3 of 7
8-K
EX-99.1
hl3ojc 5tdp
7 May 20
Results of Operations and Financial Condition
7:00am
PRE 14A
re2jc62kt36mscmqam
19 Mar 20
Preliminary proxy
4:19pm
8-K
EX-99.1
g0c5m0cvbyp dy0jj2
12 Feb 20
Results of Operations and Financial Condition
7:07am
8-K
EX-10.1
u50 7jvksii94kn
10 Apr 19
Entry into a Material Definitive Agreement
8:01am
10-K
z9s1u6szp 65
12 Feb 18
Annual report
12:00am
424B5
tehoe l68b
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
k6zmszswro 87s
30 Nov 15
Current report (foreign)
12:00am
424B5
n5p2ojm19jxsz587f3i
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
yzkmdx4h8q q4ex
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
vshd2syy0u
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
6-K
EX-99.1
ljboau10
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
p9u9ul
8 Jun 15
Business combination disclosure
12:00am
425
83ahw99pnnswx209h4
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
fi9lqto7y6y4j 88g7y
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
425
acadcwn 9fzuxy3lu
21 Apr 15
Business combination disclosure
12:00am
425
6xbf9drwb0r3eb8edv1
21 Apr 15
Business combination disclosure
12:00am